Header Logo

Connection

Marilyn Kwan to Breast Neoplasms

Back to Details
This is a "connection" page, showing publications Marilyn Kwan has written about Breast Neoplasms.
Marilyn Kwan
Connection Strength
14.679
Breast Neoplasms
  1. Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study. PLoS One. 2024; 19(9):e0310531.
    View in: PubMed
    Score: 0.543
  2. Diet quality and cardiovascular disease risk among breast cancer survivors in the Pathways Study. JNCI Cancer Spectr. 2024 Feb 29; 8(2).
    View in: PubMed
    Score: 0.523
  3. Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer. Breast Cancer Res Treat. 2022 Jun; 193(3):669-675.
    View in: PubMed
    Score: 0.459
  4. Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study. J Clin Oncol. 2022 May 20; 40(15):1647-1658.
    View in: PubMed
    Score: 0.458
  5. Description of Major Osteoporotic Fractures in Women with Invasive Breast Cancer Who Received Endocrine Therapy. JAMA Netw Open. 2021 11 01; 4(11):e2133861.
    View in: PubMed
    Score: 0.445
  6. Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study. Breast Cancer Res Treat. 2020 Feb; 180(1):187-195.
    View in: PubMed
    Score: 0.392
  7. Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy. Breast Cancer Res Treat. 2018 Apr; 168(2):523-530.
    View in: PubMed
    Score: 0.340
  8. Patterns and reasons for switching classes of hormonal therapy among women with early-stage breast cancer. Cancer Causes Control. 2017 Jun; 28(6):557-562.
    View in: PubMed
    Score: 0.323
  9. Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis. Breast Cancer Res Treat. 2017 02; 161(3):501-513.
    View in: PubMed
    Score: 0.317
  10. Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen. Breast Cancer Res Treat. 2016 Apr; 156(2):379-89.
    View in: PubMed
    Score: 0.302
  11. RE: Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741. J Natl Cancer Inst. 2016 Jan; 108(1).
    View in: PubMed
    Score: 0.297
  12. Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors. J Natl Cancer Inst. 2016 Mar; 108(3).
    View in: PubMed
    Score: 0.295
  13. Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7).
    View in: PubMed
    Score: 0.283
  14. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015 Apr 14; 15:278.
    View in: PubMed
    Score: 0.283
  15. A hybrid approach to identify subsequent breast cancer using pathology and automated health information data. Med Care. 2015 Apr; 53(4):380-5.
    View in: PubMed
    Score: 0.282
  16. Bone health history in breast cancer patients on aromatase inhibitors. PLoS One. 2014; 9(10):e111477.
    View in: PubMed
    Score: 0.274
  17. Obesity and mortality after breast cancer by race/ethnicity: The California Breast Cancer Survivorship Consortium. Am J Epidemiol. 2014 Jan 01; 179(1):95-111.
    View in: PubMed
    Score: 0.254
  18. Patient-physician interaction and quality of life in recently diagnosed breast cancer patients. Breast Cancer Res Treat. 2013 Jun; 139(2):581-95.
    View in: PubMed
    Score: 0.248
  19. Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):32-41.
    View in: PubMed
    Score: 0.239
  20. Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system. Breast Cancer Res Treat. 2012 Sep; 135(2):591-602.
    View in: PubMed
    Score: 0.235
  21. Validation of AJCC TNM staging for breast tumors diagnosed before 2004 in cancer registries. Cancer Causes Control. 2012 Sep; 23(9):1587-91.
    View in: PubMed
    Score: 0.234
  22. Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2012 Apr; 132(2):729-39.
    View in: PubMed
    Score: 0.225
  23. Clinician awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery setting. Breast Cancer Res Treat. 2012 Feb; 131(3):1029-38.
    View in: PubMed
    Score: 0.222
  24. Change in physical activity during active treatment in a prospective study of breast cancer survivors. Breast Cancer Res Treat. 2012 Jan; 131(2):679-90.
    View in: PubMed
    Score: 0.221
  25. Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2011 Nov; 130(1):195-205.
    View in: PubMed
    Score: 0.215
  26. Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study. Arch Surg. 2010 Nov; 145(11):1055-63.
    View in: PubMed
    Score: 0.208
  27. A practical method for collecting food record data in a prospective cohort study of breast cancer survivors. Am J Epidemiol. 2010 Dec 01; 172(11):1315-23.
    View in: PubMed
    Score: 0.207
  28. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010 Oct 10; 28(29):4410-6.
    View in: PubMed
    Score: 0.205
  29. Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat. 2010 Sep; 123(2):507-24.
    View in: PubMed
    Score: 0.197
  30. Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res. 2009; 11(3):R31.
    View in: PubMed
    Score: 0.188
  31. Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer. J Clin Oncol. 2009 Feb 20; 27(6):919-26.
    View in: PubMed
    Score: 0.183
  32. The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control. 2008 Dec; 19(10):1065-76.
    View in: PubMed
    Score: 0.175
  33. Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat. 2008 Jun; 109(3):573-9.
    View in: PubMed
    Score: 0.166
  34. NSAIDs and breast cancer recurrence in a prospective cohort study. Cancer Causes Control. 2007 Aug; 18(6):613-20.
    View in: PubMed
    Score: 0.162
  35. Social Support and Treatment Delays in Breast Cancer Patients Within an Integrated Health Care System. Psychooncology. 2024 Nov; 33(11):e70025.
    View in: PubMed
    Score: 0.137
  36. Trends in HR+ metastatic breast cancer survival before and after CDK4/6 inhibitor introduction in the United States: a SEER registry analysis of patients with HER2- and HER2+ metastatic breast cancer. Breast Cancer Res Treat. 2024 Nov; 208(2):223-235.
    View in: PubMed
    Score: 0.135
  37. Clinical, Epidemiologic, and Pathologic Significance of ERBB2-Low Expression in Breast Cancer. JAMA Netw Open. 2024 Mar 04; 7(3):e243345.
    View in: PubMed
    Score: 0.131
  38. Risk of adverse birth outcomes after adolescent and young adult cancer. JNCI Cancer Spectr. 2024 Jan 04; 8(1).
    View in: PubMed
    Score: 0.129
  39. Associations of Post-Diagnosis Lifestyle with Prognosis in Women with Invasive Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2023 07 05; 32(7):963-975.
    View in: PubMed
    Score: 0.125
  40. A Mendelian Randomization Analysis of 55 Genetically Predicted Metabolic Traits with Breast Cancer Survival Outcomes in the Pathways Study. Cancer Res Commun. 2023 06; 3(6):1104-1112.
    View in: PubMed
    Score: 0.125
  41. Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Breast Cancer Res Treat. 2023 Aug; 201(1):117-126.
    View in: PubMed
    Score: 0.124
  42. Neighborhood attributes and cardiovascular disease risk in breast cancer survivors: The Pathways Study. Cancer. 2023 08 01; 129(15):2395-2408.
    View in: PubMed
    Score: 0.123
  43. Plant-Based Dietary Patterns and Breast Cancer Recurrence and Survival in the Pathways Study. Nutrients. 2021 Sep 25; 13(10).
    View in: PubMed
    Score: 0.110
  44. "I Had to Make Them Feel at Ease": Narrative Accounts of How Women With Breast Cancer Navigate Social Support. Qual Health Res. 2021 05; 31(6):1056-1068.
    View in: PubMed
    Score: 0.106
  45. Hospital Characteristics and Breast Cancer Survival in the California Breast Cancer Survivorship Consortium. JCO Oncol Pract. 2020 06; 16(6):e517-e528.
    View in: PubMed
    Score: 0.101
  46. Distinct trajectories of moderate to vigorous physical activity and sedentary behavior following a breast cancer diagnosis: the Pathways Study. J Cancer Surviv. 2020 06; 14(3):393-403.
    View in: PubMed
    Score: 0.099
  47. Distinct trajectories of fruits and vegetables, dietary fat, and alcohol intake following a breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat. 2020 Jan; 179(1):229-240.
    View in: PubMed
    Score: 0.096
  48. Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system. Breast Cancer Res Treat. 2018 Aug; 170(3):623-631.
    View in: PubMed
    Score: 0.087
  49. Understanding racial/ethnic differences in breast cancer-related physical well-being: the role of patient-provider interactions. Breast Cancer Res Treat. 2018 Aug; 170(3):593-603.
    View in: PubMed
    Score: 0.087
  50. Genetic Ancestry Is not Associated with Breast Cancer Recurrence or Survival in U.S. Latina Women Enrolled in the Kaiser Permanente Pathways Study. Cancer Epidemiol Biomarkers Prev. 2017 09; 26(9):1466-1469.
    View in: PubMed
    Score: 0.083
  51. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer. Cancer. 2017 Jul 01; 123(13):2535-2542.
    View in: PubMed
    Score: 0.081
  52. Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study. JAMA Oncol. 2017 Mar 01; 3(3):351-357.
    View in: PubMed
    Score: 0.080
  53. Adiposity, post-diagnosis weight change, and risk of cardiovascular events among early-stage breast cancer survivors. Breast Cancer Res Treat. 2017 04; 162(3):549-557.
    View in: PubMed
    Score: 0.080
  54. Impact of Social and Built Environment Factors on Body Size among Breast Cancer Survivors: The Pathways Study. Cancer Epidemiol Biomarkers Prev. 2017 04; 26(4):505-515.
    View in: PubMed
    Score: 0.080
  55. Postdiagnosis social networks and breast cancer mortality in the After Breast Cancer Pooling Project. Cancer. 2017 Apr 01; 123(7):1228-1237.
    View in: PubMed
    Score: 0.079
  56. BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study. J Natl Cancer Inst. 2017 02; 109(2).
    View in: PubMed
    Score: 0.079
  57. Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study. JAMA Oncol. 2016 Sep 01; 2(9):1170-6.
    View in: PubMed
    Score: 0.078
  58. Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early-Stage Breast Cancer: The LACE and Pathways Studies. Cancer Res. 2016 09 15; 76(18):5415-22.
    View in: PubMed
    Score: 0.077
  59. Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer. J Clin Oncol. 2016 08 10; 34(23):2743-9.
    View in: PubMed
    Score: 0.076
  60. The Effect of Patient and Contextual Characteristics on Racial/Ethnic Disparity in Breast Cancer Mortality. Cancer Epidemiol Biomarkers Prev. 2016 07; 25(7):1064-72.
    View in: PubMed
    Score: 0.076
  61. Impact of very low physical activity, BMI, and comorbidities on mortality among breast cancer survivors. Breast Cancer Res Treat. 2016 Feb; 155(3):551-7.
    View in: PubMed
    Score: 0.075
  62. Validation of self-reported comorbidity status of breast cancer patients with medical records: the California Breast Cancer Survivorship Consortium (CBCSC). Cancer Causes Control. 2016 Mar; 27(3):391-401.
    View in: PubMed
    Score: 0.075
  63. Post-diagnosis social networks, and lifestyle and treatment factors in the After Breast Cancer Pooling Project. Psychooncology. 2017 04; 26(4):544-552.
    View in: PubMed
    Score: 0.074
  64. A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor-positive breast cancer prognosis. Int J Cancer. 2016 May 01; 138(9):2088-97.
    View in: PubMed
    Score: 0.074
  65. Intersection of Race/Ethnicity and Socioeconomic Status in Mortality After Breast Cancer. J Community Health. 2015 Dec; 40(6):1287-99.
    View in: PubMed
    Score: 0.074
  66. Representativeness of breast cancer cases in an integrated health care delivery system. BMC Cancer. 2015 Oct 14; 15:688.
    View in: PubMed
    Score: 0.073
  67. Contribution of the neighborhood environment and obesity to breast cancer survival: the California Breast Cancer Survivorship Consortium. Cancer Epidemiol Biomarkers Prev. 2015 Aug; 24(8):1282-90.
    View in: PubMed
    Score: 0.071
  68. History of Recreational Physical Activity and Survival After Breast Cancer: The California Breast Cancer Survivorship Consortium. Am J Epidemiol. 2015 Jun 15; 181(12):944-55.
    View in: PubMed
    Score: 0.071
  69. Statins and breast cancer stage and mortality in the Women's Health Initiative. Cancer Causes Control. 2015 Apr; 26(4):529-39.
    View in: PubMed
    Score: 0.070
  70. Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC). Cancer Epidemiol Biomarkers Prev. 2015 Feb; 24(2):361-8.
    View in: PubMed
    Score: 0.069
  71. Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study. BMC Cancer. 2014 May 29; 14:382.
    View in: PubMed
    Score: 0.066
  72. Pre- to post-diagnosis weight change and associations with physical functional limitations in breast cancer survivors. J Cancer Surviv. 2014 Dec; 8(4):539-47.
    View in: PubMed
    Score: 0.066
  73. Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression. Breast Cancer Res Treat. 2014 Apr; 144(3):689-99.
    View in: PubMed
    Score: 0.065
  74. Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):714-24.
    View in: PubMed
    Score: 0.065
  75. Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):725-34.
    View in: PubMed
    Score: 0.065
  76. The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival. Cancer Causes Control. 2013 Oct; 24(10):1821-36.
    View in: PubMed
    Score: 0.063
  77. Postdiagnosis cruciferous vegetable consumption and breast cancer outcomes: a report from the After Breast Cancer Pooling Project. Cancer Epidemiol Biomarkers Prev. 2013 Aug; 22(8):1451-6.
    View in: PubMed
    Score: 0.062
  78. Postdiagnosis supplement use and breast cancer prognosis in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2013 Jun; 139(2):529-37.
    View in: PubMed
    Score: 0.062
  79. Social networks, social support mechanisms, and quality of life after breast cancer diagnosis. Breast Cancer Res Treat. 2013 Jun; 139(2):515-27.
    View in: PubMed
    Score: 0.062
  80. High- and low-fat dairy intake, recurrence, and mortality after breast cancer diagnosis. J Natl Cancer Inst. 2013 May 01; 105(9):616-23.
    View in: PubMed
    Score: 0.061
  81. The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis. Sci Rep. 2013; 3:2246.
    View in: PubMed
    Score: 0.060
  82. The molecular and clinicopathologic characteristics of bilateral breast cancer. Sci Rep. 2013; 3:2590.
    View in: PubMed
    Score: 0.060
  83. Social networks, social support, and burden in relationships, and mortality after breast cancer diagnosis in the Life After Breast Cancer Epidemiology (LACE) study. Breast Cancer Res Treat. 2013 Jan; 137(1):261-71.
    View in: PubMed
    Score: 0.060
  84. Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat. 2012 Nov; 136(2):521-33.
    View in: PubMed
    Score: 0.059
  85. Employment status and quality of life in recently diagnosed breast cancer survivors. Psychooncology. 2013 Jun; 22(6):1411-20.
    View in: PubMed
    Score: 0.059
  86. Weight change and survival after breast cancer in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev. 2012 Aug; 21(8):1260-71.
    View in: PubMed
    Score: 0.058
  87. Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women. Am J Clin Nutr. 2012 Jul; 96(1):123-32.
    View in: PubMed
    Score: 0.058
  88. Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1115-25.
    View in: PubMed
    Score: 0.058
  89. Exercise in patients with lymphedema: a systematic review of the contemporary literature. J Cancer Surviv. 2011 Dec; 5(4):320-36.
    View in: PubMed
    Score: 0.055
  90. Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort. Cancer. 2012 Apr 15; 118(8):2048-58.
    View in: PubMed
    Score: 0.055
  91. Meeting the physical activity guidelines and survival after breast cancer: findings from the after breast cancer pooling project. Breast Cancer Res Treat. 2012 Jan; 131(2):637-43.
    View in: PubMed
    Score: 0.055
  92. The After Breast Cancer Pooling Project: rationale, methodology, and breast cancer survivor characteristics. Cancer Causes Control. 2011 Sep; 22(9):1319-31.
    View in: PubMed
    Score: 0.054
  93. Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study. Breast Cancer Res Treat. 2011 Sep; 129(2):521-9.
    View in: PubMed
    Score: 0.053
  94. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat. 2011 Apr; 126(2):529-37.
    View in: PubMed
    Score: 0.051
  95. Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. PLoS Genet. 2010 Jul 29; 6(7):e1001043.
    View in: PubMed
    Score: 0.051
  96. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2009 Nov; 118(2):395-405.
    View in: PubMed
    Score: 0.046
  97. Pure and predominantly pure intralymphatic breast carcinoma after neoadjuvant chemotherapy: an unusual and adverse pattern of residual disease. Am J Surg Pathol. 2009 Feb; 33(2):256-63.
    View in: PubMed
    Score: 0.046
  98. Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat. 2009 Oct; 117(3):653-65.
    View in: PubMed
    Score: 0.046
  99. Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):87-95.
    View in: PubMed
    Score: 0.046
  100. Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control. 2008 Dec; 19(10):1319-28.
    View in: PubMed
    Score: 0.045
  101. Lifestyle factors and survival in women with breast cancer. J Nutr. 2007 01; 137(1 Suppl):236S-242S.
    View in: PubMed
    Score: 0.040
  102. Identifying primary and recurrent cancers using a SAS-based natural language processing algorithm. J Am Med Inform Assoc. 2013 Mar-Apr; 20(2):349-55.
    View in: PubMed
    Score: 0.015

© 2025 Kaiser Permanente